Applied Genetic Technologies Corporation

(NASDAQ:AGTC)

Latest On Applied Genetic Technologies Corporation (AGTC):

Date/Time Type Description Signal Details
2022-10-24 04:31 ESTNewsSyncona to acquire Applied Genetic Technologies for ~$23.5MN/A
2022-07-26 12:48 ESTNewsAGTC receives positive feedback from FDA for manufacturing facilityN/A
2022-07-14 02:47 ESTNewsApplied Genetic Technologies stock slumps 50% on pricing $10M securities offering to fund clinical trials (update)N/A
2022-07-13 11:57 ESTNewsApplied Genetic Technologies stock slumps on pricing $10M securities offering to fund clinical trialsN/A
2022-07-12 22:36 ESTNewsApplied Genetic Technologies proposes stock offering to fund clinical trialsN/A
2022-06-10 10:51 ESTNewsApplied Genetic Technologies (AGTC) Investor Presentation - SlideshowN/A
2022-03-22 16:06 ESTNewsApplied Genetic Technologies proposes stock offering to fund clinical programs; slides 18%N/A
2022-03-22 16:05 ESTNewsApplied Genetic Technologies plunges on $9.8M stock offeringN/A
2022-02-15 18:08 ESTNewsApplied Genetic Technologies Corporation's (AGTC) CEO Sue Washer on Q2 2022 Results - Earnings Call TranscriptN/A
2022-02-14 23:52 ESTNewsApplied Genetic GAAP EPS of -$0.45 misses by $0.06N/A
2022-02-14 23:52 ESTNewsApplied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2022 Results - Earnings Call TranscriptN/A
2022-02-11 16:10 ESTNewsApplied Genetic Q2 2022 Earnings PreviewN/A
2022-01-12 18:10 ESTNewsApplied Genetic Tech: A Speculative Biotech With Potential To Turn Corner In 2022N/A
2022-01-12 00:38 ESTNewsApplied Genetic exceeds enrollment target in AGTC-501 trial for vision lossN/A
2021-12-14 09:40 ESTNewsAn Assessment Of Applied Genetic Technologies CorporationN/A
2021-11-10 02:02 ESTNewsApplied Genetic EPS misses by $0.05N/A
2021-11-10 02:01 ESTNewsApplied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q1 Fiscal Year 2022 Results - Earnings Call TranscriptN/A
2021-11-09 03:14 ESTNewsApplied Genetic FQ1 2022 Earnings PreviewN/A
2021-10-15 09:15 ESTNewsApplied Genetic Technologies appoints chief medical officerN/A
2021-09-28 11:26 ESTNewsApplied Genetic Technologies Corporation's (AGTC) CEO Sue Washer on Q4 2021 Results - Earnings Call TranscriptN/A
2021-09-24 21:53 ESTNewsApplied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q4 2021 Results - Earnings Call TranscriptN/A
2021-09-24 21:53 ESTNewsApplied Genetic Technologies Corporation 2022 Q4 - Results - Earnings Call PresentationN/A
2021-09-22 20:42 ESTNewsApplied Genetic Technologies FQ4 2021 Earnings PreviewN/A
2021-08-19 01:11 ESTNewsApplied Genetic Technologies adds Yehia Hashad to boardN/A
2021-07-20 18:41 ESTNewsDrug pricing in focus at Citi, 1Life earns another bull at Keybanc, and more in today’s analyst actionN/A
2021-07-20 18:23 ESTNewsApplied Genetic on the rise ahead of data read for Achromatopsia trialN/A
2021-07-20 18:23 ESTNewsMRIN, AGTC, ALKS and BILI among after-hours moversN/A
2021-07-20 18:23 ESTNewsApplied Genetic jumps 6% on encouraging achromatopsia trial resultsN/A
2021-07-20 18:07 ESTNewsApplied Genetic Technologies: Weak Early Clinical Ocular Results Highlight Increased RiskN/A
2021-05-05 11:11 ESTNewsEditas strengthens Q1 liquidity despite rising net loss; names new chief scientific officerN/A
2021-04-27 11:42 ESTNewsApplied Genetic trades lower after announcing the departure of chief scientific officerN/A
2021-04-27 11:41 ESTNewsCassava, Arena, and Akouos initiated as buys, Cullinan upgraded, and more in today's analyst actionN/A
2021-04-20 00:54 ESTNewsApplied Genetic licenses promoter technology to SparingVision SASN/A
2021-04-14 03:23 ESTNewsApplied Genetic and TeamedOn ink licensing deal for gene therapy developmentN/A
2021-03-09 03:03 ESTAnalyst RatingThe Analyst Target Price has decreased from $17.14 to $16.Neutral
2021-03-03 07:03 ESTAnalyst RatingThe Analyst Target Price has decreased from $17.67 to $17.14.Neutral
2021-03-01 03:03 ESTAnalyst RatingThe Analyst Target Price has increased from $16.71 to $17.67.Buy
2021-02-16 23:09 ESTNewsApplied Genetic Technologies: Leader Among Larger Peers In Gene Therapies For Certain Eye DiseasesN/A
2021-02-12 15:03 ESTAnalyst RatingThe Analyst Target Price has decreased from $17 to $16.71.Neutral
2021-02-12 14:09 ESTNewsApplied Genetic Technologies Corporation 2021 Q2 - Results - Earnings Call PresentationN/A
2021-02-12 07:03 ESTFinancialsCompany financials have been released.Neutral
2021-02-11 20:40 ESTNewsApplied Genetic EPS misses by $0.01N/A
2021-02-11 20:38 ESTNewsApplied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q2 2021 Results - Earnings Call TranscriptN/A
2021-02-10 15:03 ESTAnalyst RatingThe Analyst Target Price has increased from $15.81 to $17.Buy
2021-02-03 03:03 ESTAnalyst RatingThe Analyst Target Price has increased from $15.06 to $15.81.Buy
2021-02-02 03:04 ESTAnalyst RatingThe Analyst Target Price has increased from $14.44 to $15.06.Buy
2021-01-29 07:03 ESTAnalyst RatingThe Analyst Target Price has decreased from $14.81 to $14.44.Neutral
2021-01-28 19:54 ESTNewsApplied Genetic Technologies secures ~$74.5M capital raiseN/A
2021-01-28 03:41 ESTNewsApplied Genetic readies equity offeringN/A
2021-01-28 03:41 ESTNewsApplied Genetic' stock surges on encouraging data from achromatopsia trialsN/A

About Applied Genetic Technologies Corporation (AGTC):

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's advanced product candidates consist of three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which has completed Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate for the patients with advanced retinal disease. In addition, the company has initiated one preclinical program in otology; and three preclinical programs in targeting central nervous system disorders, including frontotemporal dementia, amyotrophic lateral sclerosis, and adrenoleukodystrophy. It has collaboration agreements with Synpromics Limited; University of Florida; Bionic Sight, LLC; and Otonomy, Inc. Applied Genetic Technologies Corporation was founded in 1999 and is headquartered in Alachua, Florida.

AGTC Quotes by TradingView

See Advanced Chart

General

  • Name Applied Genetic Technologies Corporation
  • Symbol AGTC
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 83
  • Fiscal Year EndJune
  • IPO Date2014-03-27
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.agtc.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 57.95
  • Price/Book (Most Recent Quarter) 5.22
  • Enterprise Value Revenue 70.49
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.96
  • Next Year EPS Estimate -$1.73
  • Next Quarter EPS Estimate -$0.46
  • Return on Assets -46%
  • Return on Equity -111%
  • Earnings Per Share -$0.11
  • Revenue Per Share $0
  • Gross Profit -13933000
  • Quarterly Earnings Growth -100%
View More

Highlights

  • Market Capitalization 245.28 million
  • EBITDA -3077000
  • Analyst Target Price $16
  • Book Value Per Share $1.60
View More

Share Statistics

  • Shares Outstanding 42.66 million
  • Shares Float 36.25 million
  • % Held by Insiders 102%
  • % Held by Institutions 68.32%
  • Shares Short 2.36 million
  • Shares Short Prior Month 1.63 million
  • Short Ratio 0.36
  • Short % of Float 6%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • Beta 2.28
  • 52 Week High $9.67
  • 52 Week Low $2.8
  • 50 Day Moving Average 5.45
  • 200 Day Moving Average 5.04
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Applied Genetic Technologies Corporation (AGTC) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Applied Genetic Technologies Corporation (AGTC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-11$N/A-$0.60-$0.57-4.95%
2020-09-302020-11-16$N/A-$0.60-$0.51-16.89%
2020-06-302020-09-09$N/A-$0.56-$0.46-22.27%
2020-03-312020-05-13$N/A-$0.50-$0.547.41%
2019-12-312020-02-05$2.45 million-$0.47-$0.5920.07%
2019-09-302019-11-12$N/A-$0.64-$0.63-2.4%
2019-06-302019-09-26$406000-$0.58-$0.42-38.1%
2019-03-312019-05-07$21.32 million$0.63-$0.53218.87%
2018-12-312019-02-07$5.93 million-$0.23-$0.7067.14%
2018-09-302018-11-08$14.03 million-$0.48-$0.480.81%
2018-06-302018-09-10$5.42 million-$0.37-$0.33-13.85%
2018-03-312018-05-08$3.6 million-$0.45-$0.39-14.8%
2017-12-312018-02-09$4.85 million-$0.29-$0.18-64.77%
2017-09-302017-11-07$10.32 million-$0.08-$0.1336%
2017-06-302017-09-13$8.35 million-$0.18-$0.08-140%
2017-03-312017-05-10$8.39 million-$0.05$0.07-174.07%
2016-12-312017-02-08$10.93 million$0.11$0.04193.33%
2016-09-302016-11-08$11.81 million$0.20-$0.012100%
2016-06-302016-09-12$12.11 million$0.15$0.0895.57%
2016-03-312016-05-09$12 million$0.11$0.17-35.29%
2015-12-312016-02-08$12.19 million$0.17-$0.34149.64%
2015-09-302015-11-05$11.06 million-$0.53-$0.19-178.95%
2015-06-302015-09-10$713000-$0.48-$0.40-20%
2015-03-312015-05-11$284000-$0.38-$0.33-15.15%
2014-12-312015-02-11$652000-$0.28-$0.3826.32%
2014-09-302014-11-12$705000-$0.34-$0.29-17.24%
2014-06-302014-09-26$124000-$0.32-$0.358.57%
2014-03-312014-05-14$232000-$25.45-$0.37-6778.38%

Applied Genetic Technologies Corporation (AGTC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Applied Genetic Technologies Corporation (AGTC) Chart:

Applied Genetic Technologies Corporation (AGTC) News:

Below you will find a list of latest news for Applied Genetic Technologies Corporation (AGTC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Applied Genetic Technologies Corporation (AGTC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest AGTC Trades:

Date Shares Price
Jun 13, 2022 7:50 PM EST100$0.8371
Jun 13, 2022 7:54 PM EST100$0.8374
Jun 13, 2022 7:57 PM EST200$0.8375
Jun 13, 2022 7:58 PM EST100$0.8437
Jun 13, 2022 7:59 PM EST1$0.84

Applied Genetic Technologies Corporation (AGTC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312520186812/0001193125-20-186812-index.htm
2020-02-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1273636/000000000020001069/0000000000-20-001069-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000089924320021803/0000899243-20-021803-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000089924320021805/0000899243-20-021805-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000089924320021807/0000899243-20-021807-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000089924320021811/0000899243-20-021811-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1273636/000103738920000095/0001037389-20-000095-index.htm
2019-03-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1273636/000110465919017442/0001104659-19-017442-index.htm
2019-11-21SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1273636/000110465919066219/0001104659-19-066219-index.htm
2019-11-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000110465919067696/0001104659-19-067696-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000110465919067700/0001104659-19-067700-index.htm
2019-12-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000110465919076800/0001104659-19-076800-index.htm
2020-01-27SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1273636/000110465920007216/0001104659-20-007216-index.htm
2020-09-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1273636/000110465920109236/0001104659-20-109236-index.htm
2018-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312518233245/0001193125-18-233245-index.htm
2018-08-028-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312518235147/0001193125-18-235147-index.htm
2018-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312518281373/0001193125-18-281373-index.htm
2018-10-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1273636/000119312518300301/0001193125-18-300301-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312518321849/0001193125-18-321849-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1273636/000119312518323809/0001193125-18-323809-index.htm
2018-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312518330330/0001193125-18-330330-index.htm
2018-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312518348318/0001193125-18-348318-index.htm
2019-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312519030172/0001193125-19-030172-index.htm
2019-02-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1273636/000119312519030848/0001193125-19-030848-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1273636/000119312519040572/0001193125-19-040572-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312519138835/0001193125-19-138835-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1273636/000119312519139735/0001193125-19-139735-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312519180690/0001193125-19-180690-index.htm
2019-07-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312519203040/0001193125-19-203040-index.htm
2019-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312519212072/0001193125-19-212072-index.htm
2019-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312519255961/0001193125-19-255961-index.htm
2019-09-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1273636/000119312519255968/0001193125-19-255968-index.htm
2019-09-26424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1273636/000119312519255981/0001193125-19-255981-index.htm
2019-09-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1273636/000119312519255990/0001193125-19-255990-index.htm
2019-10-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1273636/000119312519277798/0001193125-19-277798-index.htm
2019-11-04DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1273636/000119312519283531/0001193125-19-283531-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312519290059/0001193125-19-290059-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1273636/000119312519290072/0001193125-19-290072-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312519304427/0001193125-19-304427-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312519309304/0001193125-19-309304-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312520005429/0001193125-20-005429-index.htm
2020-01-29S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1273636/000119312520018614/0001193125-20-018614-index.htm
2020-02-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1273636/000119312520025374/0001193125-20-025374-index.htm
2020-02-05S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1273636/000119312520025421/0001193125-20-025421-index.htm
2020-02-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1273636/000119312520025472/0001193125-20-025472-index.htm
2020-02-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1273636/000119312520025478/0001193125-20-025478-index.htm
2020-02-07POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1273636/000119312520027055/0001193125-20-027055-index.htm
2020-02-07424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1273636/000119312520028177/0001193125-20-028177-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1273636/000119312520031460/0001193125-20-031460-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1273636/000119312520036614/0001193125-20-036614-index.htm
2020-04-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312520099924/0001193125-20-099924-index.htm
2020-04-088-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312520101339/0001193125-20-101339-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312520141033/0001193125-20-141033-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1273636/000119312520141610/0001193125-20-141610-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312520186812/0001193125-20-186812-index.htm
2020-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312520196790/0001193125-20-196790-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312520213063/0001193125-20-213063-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312520215552/0001193125-20-215552-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312520241522/0001193125-20-241522-index.htm
2020-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000119312520248061/0001193125-20-248061-index.htm
2020-09-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1273636/000119312520249103/0001193125-20-249103-index.htm
2020-09-18S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1273636/000119312520249106/0001193125-20-249106-index.htm
2020-11-02DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1273636/000119312520283941/0001193125-20-283941-index.htm
2020-11-02DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1273636/000119312520283945/0001193125-20-283945-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1273636/000125889719001012/0001258897-19-001012-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1273636/000125889720000783/0001258897-20-000783-index.htm
2018-07-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000020/0001273636-18-000020-index.htm
2018-07-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000022/0001273636-18-000022-index.htm
2018-07-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000024/0001273636-18-000024-index.htm
2018-07-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000026/0001273636-18-000026-index.htm
2018-07-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000028/0001273636-18-000028-index.htm
2018-07-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000030/0001273636-18-000030-index.htm
2018-07-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000032/0001273636-18-000032-index.htm
2018-07-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000034/0001273636-18-000034-index.htm
2018-07-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000036/0001273636-18-000036-index.htm
2018-07-304/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000038/0001273636-18-000038-index.htm
2018-07-304/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000040/0001273636-18-000040-index.htm
2018-07-304/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000042/0001273636-18-000042-index.htm
2018-07-304/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000044/0001273636-18-000044-index.htm
2018-07-304/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000046/0001273636-18-000046-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000049/0001273636-18-000049-index.htm
2018-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000051/0001273636-18-000051-index.htm
2018-09-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000054/0001273636-18-000054-index.htm
2018-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000056/0001273636-18-000056-index.htm
2018-10-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000058/0001273636-18-000058-index.htm
2018-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000060/0001273636-18-000060-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000063/0001273636-18-000063-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000065/0001273636-18-000065-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000067/0001273636-18-000067-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000071/0001273636-18-000071-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000073/0001273636-18-000073-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000075/0001273636-18-000075-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000077/0001273636-18-000077-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000079/0001273636-18-000079-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000081/0001273636-18-000081-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000083/0001273636-18-000083-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000085/0001273636-18-000085-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363618000087/0001273636-18-000087-index.htm
2019-01-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000003/0001273636-19-000003-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000006/0001273636-19-000006-index.htm
2019-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000008/0001273636-19-000008-index.htm
2019-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000009/0001273636-19-000009-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000010/0001273636-19-000010-index.htm
2019-05-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000011/0001273636-19-000011-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000012/0001273636-19-000012-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000015/0001273636-19-000015-index.htm
2019-06-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000017/0001273636-19-000017-index.htm
2019-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000019/0001273636-19-000019-index.htm
2019-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000022/0001273636-19-000022-index.htm
2019-07-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000024/0001273636-19-000024-index.htm
2019-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000026/0001273636-19-000026-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000032/0001273636-19-000032-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000033/0001273636-19-000033-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000034/0001273636-19-000034-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000035/0001273636-19-000035-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000036/0001273636-19-000036-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000039/0001273636-19-000039-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000041/0001273636-19-000041-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000043/0001273636-19-000043-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000045/0001273636-19-000045-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000047/0001273636-19-000047-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000050/0001273636-19-000050-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363619000052/0001273636-19-000052-index.htm
2020-08-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363620000004/0001273636-20-000004-index.htm
2020-08-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000127363620000005/0001273636-20-000005-index.htm
2020-06-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1273636/000131924420000092/0001319244-20-000092-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1273636/000138713120001829/0001387131-20-001829-index.htm
2018-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1273636/000156459018022873/0001564590-18-022873-index.htm
2018-09-1110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1273636/000156459018022913/0001564590-18-022913-index.htm
2019-04-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000177378219000001/0001773782-19-000001-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000177378219000002/0001773782-19-000002-index.htm
2019-05-083/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1273636/000177378219000003/0001773782-19-000003-index.htm
2020-02-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1273636/999999999520000282/9999999995-20-000282-index.htm
2020-01-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1273636/999999999720000128/9999999997-20-000128-index.htm

Applied Genetic Technologies Corporation (AGTC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Applied Genetic Technologies Corporation (AGTC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 102%
Institutional Ownership: 6832%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-12-14Mark S ShearmanChief Scientific OfficerSell3,000.003.3510,052.700.00https://www.sec.gov/Archives/edgar/data/1273636/000127363618000081/0001273636-18-000081-index.htm
2018-12-14James RosenDirectorBuy1,000.003.383,381.001,000.00https://www.sec.gov/Archives/edgar/data/1273636/000127363618000087/0001273636-18-000087-index.htm
2019-12-26Patrick Johan Hendrik Krol10% Share HolderSell81,162.005.24425,288.881,780,762.00https://www.sec.gov/Archives/edgar/data/1273636/000110465919076800/0001104659-19-076800-index.htm
2019-11-19Patrick Johan Hendrik Krol10% Share HolderBuy2,544.002.797,097.761,861,924.00https://www.sec.gov/Archives/edgar/data/1273636/000110465919067700/0001104659-19-067700-index.htm
2018-12-14Susan B. WasherPresident and CEOBuy2,380.003.347,949.2022,708.00https://www.sec.gov/Archives/edgar/data/1273636/000127363618000079/0001273636-18-000079-index.htm
2019-09-18Susan B. WasherPresident and CEOBuy5,700.003.5019,950.0028,408.00https://www.sec.gov/Archives/edgar/data/1273636/000127363619000039/0001273636-19-000039-index.htm
2018-12-14William A. SullivanChief Financial OfficerBuy3,000.003.339,990.003,000.00https://www.sec.gov/Archives/edgar/data/1273636/000127363618000083/0001273636-18-000083-index.htm
2019-05-28Scott KoenigDirectorBuy32,018.000.3511,206.3034,246.00https://www.sec.gov/Archives/edgar/data/1273636/000127363619000012/0001273636-19-000012-index.htm
2018-12-14William AliskiDirectorBuy1,200.003.243,882.003,700.00https://www.sec.gov/Archives/edgar/data/1273636/000127363618000085/0001273636-18-000085-index.htm
2019-08-15Mark S ShearmanChief Scientific OfficerBuy39,000.0039,000.00https://www.sec.gov/Archives/edgar/data/1273636/000127363619000035/0001273636-19-000035-index.htm
2019-08-15Stephen W PotterVP and Chief Business OfficerBuy39,000.0040,400.00https://www.sec.gov/Archives/edgar/data/1273636/000127363619000034/0001273636-19-000034-index.htm
2018-08-13Matthew FeinsodInterim Chief Medical OfficerBuy2,000.0041,976.00https://www.sec.gov/Archives/edgar/data/1273636/000127363618000049/0001273636-18-000049-index.htm
2018-09-11Matthew FeinsodInterim Chief Medical OfficerBuy2,000.0043,384.00https://www.sec.gov/Archives/edgar/data/1273636/000127363618000051/0001273636-18-000051-index.htm
2018-10-11Matthew FeinsodInterim Chief Medical OfficerBuy2,000.0044,699.00https://www.sec.gov/Archives/edgar/data/1273636/000127363618000058/0001273636-18-000058-index.htm
2018-11-12Matthew FeinsodInterim Chief Medical OfficerBuy2,000.0046,087.00https://www.sec.gov/Archives/edgar/data/1273636/000127363618000060/0001273636-18-000060-index.htm
2018-12-11Matthew FeinsodInterim Chief Medical OfficerBuy2,000.0047,402.00https://www.sec.gov/Archives/edgar/data/1273636/000127363618000077/0001273636-18-000077-index.htm
2019-01-11Matthew FeinsodInterim Chief Medical OfficerBuy2,000.0048,791.00https://www.sec.gov/Archives/edgar/data/1273636/000127363619000003/0001273636-19-000003-index.htm
2019-02-11Matthew FeinsodInterim Chief Medical OfficerBuy2,000.0050,078.00https://www.sec.gov/Archives/edgar/data/1273636/000127363619000006/0001273636-19-000006-index.htm
2019-03-11Matthew FeinsodInterim Chief Medical OfficerBuy2,000.0051,287.00https://www.sec.gov/Archives/edgar/data/1273636/000127363619000008/0001273636-19-000008-index.htm
2019-04-11Matthew FeinsodInterim Chief Medical OfficerBuy2,000.0052,620.00https://www.sec.gov/Archives/edgar/data/1273636/000127363619000009/0001273636-19-000009-index.htm
2019-05-13Matthew FeinsodInterim Chief Medical OfficerBuy2,000.0054,014.00https://www.sec.gov/Archives/edgar/data/1273636/000127363619000010/0001273636-19-000010-index.htm
2019-06-11Matthew FeinsodInterim Chief Medical OfficerBuy2,000.0055,329.00https://www.sec.gov/Archives/edgar/data/1273636/000127363619000015/0001273636-19-000015-index.htm
2019-07-11Matthew FeinsodInterim Chief Medical OfficerBuy2,000.0056,644.00https://www.sec.gov/Archives/edgar/data/1273636/000127363619000019/0001273636-19-000019-index.htm
2018-12-14William AliskiDirectorBuy4,300.003.2513,975.008,000.00https://www.sec.gov/Archives/edgar/data/1273636/000127363618000085/0001273636-18-000085-index.htm
2018-12-14William AliskiDirectorBuy500.003.241,620.008,500.00https://www.sec.gov/Archives/edgar/data/1273636/000127363618000085/0001273636-18-000085-index.htm